New malaria pill for tiny babies shows promise, study cut short
NCT ID NCT04300309
First seen Jan 15, 2026 · Last updated May 23, 2026 · Updated 22 times
Summary
This study tested a new, easy-to-take malaria tablet for infants and newborns weighing less than 5 kg who had uncomplicated malaria. The goal was to see if the medicine was safe and worked well in this very young group. The study was stopped early, but the information gathered helps doctors understand how to treat malaria in the smallest patients.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PLASMODIUM FALCIPARUM MALARIA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Novartis Investigative Site
Nanoro, Burkina Faso
-
Novartis Investigative Site
Ouagadougou, Burkina Faso
-
Novartis Investigative Site
Kisantu, Bas Kongo, Democratic Republic of the Congo
Conditions
Explore the condition pages connected to this study.